BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29609096)

  • 1. Reactive oxygen species activate differentiation gene transcription of acute myeloid leukemia cells via the JNK/c-JUN signaling pathway.
    Lam CF; Yeung HT; Lam YM; Ng RK
    Leuk Res; 2018 May; 68():112-119. PubMed ID: 29609096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-steroidal anti-inflammatory drugs Sulindac sulfide and Diclofenac induce apoptosis and differentiation in human acute myeloid leukemia cells through an AP-1 dependent pathway.
    Singh R; Cadeddu RP; Fröbel J; Wilk CM; Bruns I; Zerbini LF; Prenzel T; Hartwig S; Brünnert D; Schroeder T; Lehr S; Haas R; Czibere A
    Apoptosis; 2011 Sep; 16(9):889-901. PubMed ID: 21739277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Constitutively active MAP kinase kinase (MEK1) stimulates SAP kinase and c-Jun transcriptional activity in U937 human leukemic cells.
    Franklin CC; Kraft AS
    Oncogene; 1995 Dec; 11(11):2365-74. PubMed ID: 8570188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactive oxygen species-mediated activation of AMP-activated protein kinase and c-Jun N-terminal kinase plays a critical role in beta-sitosterol-induced apoptosis in multiple myeloma U266 cells.
    Sook SH; Lee HJ; Kim JH; Sohn EJ; Jung JH; Kim B; Kim JH; Jeong SJ; Kim SH
    Phytother Res; 2014 Mar; 28(3):387-94. PubMed ID: 23640957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGF-I plus E2 induces proliferation via activation of ROS-dependent ERKs and JNKs in human breast carcinoma cells.
    Lin CW; Yang LY; Shen SC; Chen YC
    J Cell Physiol; 2007 Sep; 212(3):666-74. PubMed ID: 17458902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costunolide-induced apoptosis in human leukemia cells: involvement of c-jun N-terminal kinase activation.
    Choi JH; Lee KT
    Biol Pharm Bull; 2009 Oct; 32(10):1803-8. PubMed ID: 19801848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-Jun N-terminal kinase activation failure is a new mechanism of anthracycline resistance in acute myeloid leukemia.
    Lagadinou ED; Ziros PG; Tsopra OA; Dimas K; Kokkinou D; Thanopoulou E; Karakantza M; Pantazis P; Spyridonidis A; Zoumbos NC
    Leukemia; 2008 Oct; 22(10):1899-908. PubMed ID: 18650843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation-associated genes regulated by TPA-induced c-Jun expression via a PKC/JNK pathway in KYSE450 cells.
    Yu X; Luo A; Zhou C; Ding F; Wu M; Zhan Q; Liu Z
    Biochem Biophys Res Commun; 2006 Mar; 342(1):286-92. PubMed ID: 16480952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P53 activation plays a crucial role in silibinin induced ROS generation via PUMA and JNK.
    Fan S; Qi M; Yu Y; Li L; Yao G; Tashiro S; Onodera S; Ikejima T
    Free Radic Res; 2012 Mar; 46(3):310-9. PubMed ID: 22283740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R; Iñiguez MA; Fresno M
    Cancer Res; 2004 Aug; 64(15):5162-71. PubMed ID: 15289320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phorbol 12-myristate 13-acetate protects against tumor necrosis factor (TNF)-induced necrotic cell death by modulating the recruitment of TNF receptor 1-associated death domain and receptor-interacting protein into the TNF receptor 1 signaling complex: Implication for the regulatory role of protein kinase C.
    Byun HS; Park KA; Won M; Yang KJ; Shin S; Piao L; Kwak JY; Lee ZW; Park J; Seok JH; Liu ZG; Hur GM
    Mol Pharmacol; 2006 Sep; 70(3):1099-108. PubMed ID: 16798936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.
    Zada AA; Singh SM; Reddy VA; Elsässer A; Meisel A; Haferlach T; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Apr; 22(15):2296-308. PubMed ID: 12700665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of oxidative stress in taxol-induced apoptosis in chronic myelogenous leukemia K562 cells.
    Meshkini A; Yazdanparast R
    Exp Toxicol Pathol; 2012 May; 64(4):357-65. PubMed ID: 21074392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary alpha T3-1 cell line is mediated by protein kinase C, c-Src, and CDC42.
    Levi NL; Hanoch T; Benard O; Rozenblat M; Harris D; Reiss N; Naor Z; Seger R
    Mol Endocrinol; 1998 Jun; 12(6):815-24. PubMed ID: 9626657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis.
    Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P
    J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mitogen-activated protein kinase pathway inhibits ceramide-induced terminal differentiation of a human monoblastic leukemia cell line, U937.
    Ragg SJ; Kaga S; Berg KA; Ochi A
    J Immunol; 1998 Aug; 161(3):1390-8. PubMed ID: 9686602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive c-jun N-terminal kinase activity in acute myeloid leukemia derives from Flt3 and affects survival and proliferation.
    Hartman AD; Wilson-Weekes A; Suvannasankha A; Burgess GS; Phillips CA; Hincher KJ; Cripe LD; Boswell HS
    Exp Hematol; 2006 Oct; 34(10):1360-76. PubMed ID: 16982329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of mitogen-activated protein kinase in signal transducer and activator of transcription-1 mediated differentiation induced by bortezomib in acute myeloid leukemia cells.
    Zhou X; Fang Y; Jing H; Zhong L; Luo P; Song H; Yang B; He Q
    Mol Carcinog; 2013 Jan; 52(1):18-28. PubMed ID: 22006557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.